{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:43:36Z","timestamp":1762098216695},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1990,3,1]],"date-time":"1990-03-01T00:00:00Z","timestamp":636249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1990,3]]},"DOI":"10.1007\/bf01409488","type":"journal-article","created":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T16:13:34Z","timestamp":1113322414000},"page":"S158-S163","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of carvedilol in renal hypertension"],"prefix":"10.1007","volume":"38","author":[{"given":"T.","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fukiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1","volume-title":"Beta blockers in the treatment of cardiovascular disease","author":"BNC Prichard","year":"1984","unstructured":"Prichard BNC, Owens CWI (1984) Clinical pharmacology of beta-adrenoceptor blocking drugs. In: Kostis JB, Felice EA de (eds) Beta blockers in the treatment of cardiovascular disease. Raven Press, New York, pp 1?56"},{"issue":"Suppl 2","key":"CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-198300252-00089","volume":"25","author":"BNC Prichard","year":"1983","unstructured":"Prichard BNC (1983) Mechanisms of myocardial infarct prevention with beta-adrenergic blocking drugs. Drugs 25 [Suppl 2]: 295?302","journal-title":"Drugs"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/hrt.34.10.1042","volume":"34","author":"ET O'Brien","year":"1972","unstructured":"O'Brien ET, MacKinnon J (1972) Propranolol and polythiazide in treatment of hypertension. Br Heart J 34: 1042?1051","journal-title":"Br Heart J"},{"issue":"Suppl D","key":"CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/eurheartj\/4.suppl_D.13","volume":"4","author":"PW Leeuw De","year":"1983","unstructured":"De Leeuw PW, Birkenh\u00e4ger WH (1983) Renal effects of beta blockade in essential hypertension. Eur Heart J 4 [Suppl D]: 13?17","journal-title":"Eur Heart J"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00003495-198223030-00002","volume":"23","author":"R Wilkinson","year":"1982","unstructured":"Wilkinson R (1982) Beta-blockers and renal function. Drugs 23: 195?206","journal-title":"Drugs"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005344-198703000-00009","volume":"9","author":"G Sponer","year":"1987","unstructured":"Sponer G, Bartsh W, Strein K, M\u00fcller-Beckman B, B\u00f6hm E (1987) Pharmacological profile of carvedilol as a ?-blocking agent with vasodilating and hypotensive properties. J Cardiovasc Pharmacol 9: 317?326","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0021-5198(19)58232-4","volume":"43","author":"K Irie","year":"1987","unstructured":"Irie K, Takasuna K, Kunitada S, Mori T, Ashida S (1987) Hemodynamic profile of carvedilol, a new ?-adrenoceptor blocking agent with vasodilating properties in conscious SHR. Jpn J Pharmacol 43 [Suppl]: 142","journal-title":"Jpn J Pharmacol"},{"issue":"Suppl 6","key":"CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003495-198800366-00027","volume":"36","author":"T Tamaki","year":"1988","unstructured":"Tamaki T, Hasui K, Yamamoto A, Aki Y, Shoji T, Nakamura A, Kimura S, Fukui K, Iwao H, Abe Y (1988) Renal vasodilatory action of carvedilol. Drugs 36 [Suppl 6]: 155?159","journal-title":"Drugs"},{"issue":"Suppl 11","key":"CR9","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00005344-198710004-00015","volume":"10","author":"G Neugebauer","year":"1987","unstructured":"Neugebauer G, Akpan W, M\u00f6llendorff E, Neubert P, Reiff K (1987) Pharmacokinetics and disposition of carvedilol in humans. J Cardiovasc Pharmacol 10 [Suppl 11]: S85-S88","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 6","key":"CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00003495-198800366-00022","volume":"36","author":"M Kohno","year":"1988","unstructured":"Kohno M, Takeda T, Ishii M, Saruta T, Mizuno Y, Yoshimura M, Kubo S, Fukiyama K, Fujishima M (1988) Therapeutic benefits and safety of carvedilol in renal hypertension. An open, shortterm study. Drugs 36 [Suppl 6]: 129?135","journal-title":"Drugs"},{"issue":"Suppl 11","key":"CR11","first-page":"S81","volume":"10","author":"LX Cubeddu","year":"1987","unstructured":"Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR (1987) Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol. J Cardiovasc Pharmacol 10 [Suppl 11]: S81-S84","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 11","key":"CR12","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00005344-198710111-00024","volume":"10","author":"AG Dupont","year":"1987","unstructured":"Dupont AG, Van der Niepen P, Taeymans Y, Ingels M, Piepsz A, Bossuyt AM, Block P, Six OR, Jonckheer MH, Vanhaelst L (1987) Effect of carvedilol on ambulatory blood pressure, renal hemodynamics and cardiac function in essential hypertension. J Cardiovasc Pharmacol 10 [Suppl 11]: S130-S136","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 6","key":"CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00003495-198800366-00029","volume":"36","author":"M Kohno","year":"1988","unstructured":"Kohno M, Murakawa K, Okamura M, Yasunari K, Yokokawa K, Horio T, Inoue T, Takeda T (1988) Effects of long term administration of carvedilol on renal haemodynamics and functions in DOCA salt-induced accelerated hypertension of spontaneously hypertensive rats. Drugs 36 [Suppl 6]: 165?168","journal-title":"Drugs"},{"issue":"Suppl 6","key":"CR14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2165\/00003495-198800366-00028","volume":"36","author":"H Nakamoto","year":"1988","unstructured":"Nakamoto H, Suzuki H, Katsumata H, Ohishi A, Saruta T, Sakaguchi H (1988) Effects of carvedilol on renal function and blood pressure in three-fifths nephrectomized spontaneously hypertensive rats loaded with high salt. Drugs 36 [Suppl 6]: 160?164","journal-title":"Drugs"},{"issue":"Suppl 6","key":"CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2165\/00003495-198800366-00025","volume":"36","author":"H Hakusui","year":"1988","unstructured":"Hakusui H, Fujimaki M (1988) Pharmacokinetics of carvedilol in hypertensive patients with renal failure. Drugs 36 [Suppl 6]: 144?147","journal-title":"Drugs"},{"key":"CR16","first-page":"302","volume":"100","author":"M Ikeda","year":"1979","unstructured":"Ikeda M, Aoki K, Arakawa N, Inagaki Y (1979) Clinical efficacy of Diltiazem (Herbesser) in patients with essential hypertension ? a placebo-controlled double-blind comparative study. Igaku No Ayumi 100: 302?320","journal-title":"Igaku No Ayumi"},{"key":"CR17","first-page":"186","volume":"108","author":"K Ohshima","year":"1979","unstructured":"Ohshima K, Goto Y, Masuyama Y, Kajiwara N (1979) Clinical evaluation of prazosin in patients with essential hypertension. Igaku No Ayumi 108: 186?201","journal-title":"Igaku No Ayumi"},{"key":"CR18","first-page":"425","volume":"139","author":"M Ikeda","year":"1986","unstructured":"Ikeda M, Masuyama Y, Yoshinaga H, Inagaki Y, Ishii T (1986) Clinical efficacy of amosulalol (YM-09538) in patients with essential hypertension. Igaku No Ayumi 139: 425?453","journal-title":"Igaku No Ayumi"},{"issue":"Suppl 6","key":"CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-198800366-00014","volume":"36","author":"T Ogihara","year":"1988","unstructured":"Ogihara T, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T, Arakawa K, Ikeda M (1988) Dose-effect relationship of carvedilol in essential hypertension. An open study. Drugs 36 [Suppl 6]: 75?81","journal-title":"Drugs"},{"issue":"Suppl 6","key":"CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003495-198800366-00020","volume":"36","author":"M Yasujima","year":"1988","unstructured":"Yasujima M, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T, Arakawa K, Ikeda M (1988) Efficacy and tolerance of carvedilol in combination with a thiazide diuretic in the treatment of essential hypertension. An open study. Drugs 36 [Suppl 6]: 118?123","journal-title":"Drugs"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01409488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01409488\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01409488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:37:55Z","timestamp":1625737075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01409488"}},"subtitle":["A multicenter open trial"],"short-title":[],"issued":{"date-parts":[[1990,3]]},"references-count":20,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1990,3]]}},"alternative-id":["BF01409488"],"URL":"https:\/\/doi.org\/10.1007\/bf01409488","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,3]]}}}